Curbing dubious prescribing practices

NHS England is to publish a national list of low-value drugs as part of a new drive to reduce GPs’ prescribing costs.


The review will initially focus on 10 treatments, which the NHS estimates could save $208 million a year.

These products — which include lidocaine plasters for treatment of postherpetic neuralgia, liothyronine for underactive thyroid and gluten-free foods — have been identified as ineffective, unnecessary, unsafe or inappropriate for the NHS to prescribe,